(Cbz-LGR)2-[Rh110] is a fluorogenic peptide substrate for Trypanosoma cruzi alkaline peptidase, the organism causing South American trypanosomiasis.
See full description
Ashall et al., (1990). Substrate specificity and inhibitor sensitivity of a trypanosomatid alkaline peptidase. Biochim Biophys Acta., 1035(3): 293. PMID: 2207124.
Drake et al., (1990). Detection of peptidase activities in Trypanosoma cruzi using chromogenic and fluorogenic substrates. Biochem. Soc. Trans., 18: 866.
The protozoan Trypanosoma cruzi that causes South American trypanosomiasis expresses peptidases during its entire parasitic life cycle. Understanding better the function and specificity of the peptidases may lead to new inhibitors and potential therapies. It has been shown this alkaline peptidase has a preference for basic amino acids at position one and position two of the substrate. The sequence Leu-Gly-Arg was shown to have a high Km and high Vmax compared to other peptides tested.
Provided here is a fluorogenic peptide substrate for Trypanosoma cruzi alkaline peptidase. In its entire state, this peptide is not fluorescent. However, this peptide is cleaved by T. cruzi alkaline peptidase. Upon rhodamine 110 fluorophore release, fluorescence can then be detected. This peptide, therefore, allows for the quantification of T. cruzi alkaline peptidase activity. Rhodamine 110 is a widely used red fluorescent probe.
Search our datasheets by catalogue number, peptide sequence or name.
Discover more about how we can support you and our products.
Find answers to common queries about our products and company.
Cambridge Research Biochemicals 17-18 Belasis Court, Belasis Hall Technology Park Billingham TS23 4AZ
t +44 01642 567 183